Remzistotug clinical trials

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

This study looks at a new treatment called remzistotug for advanced cancers that haven't responded to usual treatments. It's the first time it will be tested in people to check if it's safe and how it works in the body.